TRILLIUM THERAPEUTICS INC. Operating Expenses
TRILLIUM THERAPEUTICS INC. reported Operating Expenses of $19.45 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. operating expenses for the quarter ending 2021-09-30 was $19.45M, a 49.69% increase year-over-year.
- TRILLIUM THERAPEUTICS INC. operating expenses for the quarter ending 2021-06-30 was $18.68M, a 21.76% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. operating expenses for the quarter ending 2021-03-31 was $11.31M, a 32.10% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. operating expenses for the quarter ending 2020-12-31 was $8.07M.
- TRILLIUM THERAPEUTICS INC. operating expenses for fiscal 2020 was $61.60M, a 90.06% increase from fiscal 2019.
- TRILLIUM THERAPEUTICS INC. operating expenses for fiscal 2019 was $32.41M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2021-09-30 | $19.45M 10-Q · filed 2021-11-12 | $38.13M derived: sum of 2 quarters · filed 2021-11-12 | $49.44M 10-Q · filed 2021-11-12 | $57.52M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $18.68M 10-Q · filed 2021-08-13 | $29.99M 10-Q · filed 2021-08-13 | $38.06M derived: sum of 3 quarters · filed 2021-08-13 | $51.06M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | $11.31M 10-Q · filed 2021-05-07 | $19.39M derived: sum of 2 quarters · filed 2021-05-07 | $32.38M derived: sum of 3 quarters · filed 2021-11-12 | $56.25M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $8.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $21.07M derived: sum of 2 quarters · filed 2021-11-12 | $44.94M derived: sum of 3 quarters · filed 2021-11-12 | $61.60M 10-K · filed 2021-03-18 |
| 2020-09-30 | $12.99M 10-Q · filed 2021-11-12 | $36.87M derived: sum of 2 quarters · filed 2021-11-12 | $53.53M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $23.87M 10-Q · filed 2021-08-13 | $40.53M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $16.66M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $32.41M 10-K · filed 2021-03-18 |